Effects of intravenous administration of dimethyl sulfoxide on cardiopulmonary and clinicopathologic variables in awake or halothane- anesthetized horses

Journal of the American Veterinary Medical Association

Volumn 225, Issue 4, 2004, Pages 560-566

  Lin, Hui Chu ^a   Johnson, Christopher R ^a,b   Duran, Sue H ^a   Waldridge, Bryan M ^a  

^a AUBURN UNIVERSITY   (United States)

^b Woodford Veterinary Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DIMETHYL SULFOXIDE; ELECTROLYTE; FIBRINOGEN; HALOTHANE;

AGITATION; ANESTHESIA; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; BREATHING RATE; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FIBRINOGEN BLOOD LEVEL; FLUID THERAPY; HEART RATE; HORSE; LEUKOCYTE; NONHUMAN; PROSPECTIVE STUDY; SURGICAL STRESS; SURVIVAL RATE; TACHYCARDIA; WAKEFULNESS;

ANALGESICS, NON-NARCOTIC; ANESTHETICS, INHALATION; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CROSS-OVER STUDIES; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOTHANE; HEART RATE; HORSES; INFUSIONS, INTRAVENOUS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RESPIRATION;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 4043137506     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.225.560     Document Type: Article

References (28)

1. Berlinger DL, Ruhman AG. The influence of dimethyl sulfoxide on fibroblastic proliferation. Ann N Y Acad Sci 1967;141:159-164.
2. Wong LK, Reinertson EL. Clinical consideration for dimethyl sulfoxide. Iowa State Vet 1984;46:89-95.
3. Brayton CF. Dimethyl sulfoxide (DMSO): a review. Cornell Vet 1986;76:61-90.
4. Wood DC, Wood J. Pharmacologic and biochemical considerations of dimethyl sulfoxide. Ann N Y Acad Sci 1975;243:7-19.
5. Booth NH. Topical agents. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. 6th ed. Ames, Iowa: Iowa State University Press, 1991;721-744.
6. Alsup EM, DeBowes RM. Dimethyl sulfoxide. J Am Vet Med Assoc 1984;185:1011-1014.
7. Moore RM. Principle of therapy: antiinflammatory drug therapy in horses. In: Colahan PT, Mayhew IG, Merritt AM, et al, eds. Manual of equine medicine and surgery. 5th ed. St Louis: Mosby Year Book Inc, 1999;44-49.
8. Quill TJ. Blood pressure monitoring. In: Ehrenwerth J, Eisenkraft JB, eds. Anesthesia equipment: principles and application. St Louis: Mosby Year Book Inc, 1993;275-283.
9. Wagner AE. Venous and arterial catheterization and fluid therapy. In: Muir WW, Hubbell JAE, eds. Equine anesthesia: monitoring and emergency therapy. St Louis: Mosby Year Book Inc, 1991;140-152.
10. Meagher DM. Clinical evaluation and management of shock in the equine patient. Vet Clin North Am Equine Pract 1976;6:245-255.
11. Noel PR, Barnett KC, Davies RE, et al. The toxicity of dimethyl sulfoxide (DMSO) for the dog, pig, rat, and rabbit. Toxicology 1975;3:143-169.
12. Steffey EP, Zinkl J, Rowland D Jr. Minimal changes in blood cell counts and biochemical values associated with prolonged isoflurane anesthesia of horses. Am J Vet Res 1979;40:1646-1648.
13. Steffey EP, Farver T, Zinkl J, et al. Alterations in horse blood cell count and biochemical values after halothane anesthesia. Am J Vet Res 1980;41:934-939.
14. Shlafer M, Karao AM. Pharmacological effects of dimethyl sulfoxide on the mammalian myocardium. Ann N Y Acad Sci 1975; 243:110-121.
15. Muir WW, Mason D. Cardiovascular system. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Lumb & Jones' veterinary anesthesia. 3rd ed. Baltimore: The Williams & Wilkins Co, A Lea & Febiger Book, 1996;62-114.
16. Steffey EP, Rowland D Jr. Cardiovascular effects of halothane in horses. Am J Vet Res 1978;39:611-615.
17. Thurmon JC, Davis-Neff C, Davis LE, et al. Xylazine hydrochloride-induced hyperglycemia and hypoinsulinemia in thoroughbred horses. J Vet Pharmacol Ther 1982;5:241-245.
18. Steffey EP, Rowland D Jr, Giri S, et al. Enflurane, halothane, and isoflurane potency in horses. Am J Vet Res 1977;38:1037-1039.
19. Marini RP, Jackson LR, Esteves MI, et al. Effect of isoflurane on hematologic variables in ferrets. Am J Vet Res 1994;55:1479-1483.
20. Scribner BH, Fremont-Smith K, Burnell JM. The effect of acute respiratory acidosis on the internal equilibrium of potassium. J Clin Invest 1955;34:1276-1285.
21. Wright BD, DiGiovanni AJ. Respiratory alkalosis, hypokalemia, and repeated ventricular fibrillation associated with mechanical ventilation. Anesth Analg 1969;48:467-473.
22. Hasan H, Tomlin PJ. Hypercapnia and hyperkalemia. Anaesthesia 1979;34:897-899.
23. Muir WW, Wagner AE, Buchanan C. Effects of acute hyperventilation on serum potassium in the dog. Vet Surg 1990;19:83-87.
24. Grady JL, Steffey EP, Hodgson DS, et al. Arterial hypotension and the development of postanesthetic myopathy in halothane-anesthetized horses. Am J Vet Res 1987;48:192-197.
25. Miao N, Frazer MJ, Lynch C III. Anesthetic action of calcium uptake and calcium-dependent adenosine triphosphatase activity of cardiac sarcoplasmic reticulum. In: Bosnjak ZJ, Kampins JP, eds. Advances in pharmacology. San Diego: Academic Press Inc, 1994;145-165.
26. Grubb TL, Benson GJ, Foreman JH, et al. Hemodynamic effects of ionized calcium in horses anesthetized with halothane or isoflurane. Am J Vet Res 1999;60:1430-1435.
27. DiBartola SP. Disorders of phosphorus: hypophosphatemia and hyperphosphatemia. In: Fluid therapy in small animal practice. Philadelphia: WB Saunders Co, 1992;177-191.
28. O'Connor LR, Klein KL, Bethune JE. Hyperphosphatemia in lactic acidosis. N Engl J Med 1977;297:707-709.